Seelos therapeutics announces issuance of a patent for trehalose (sls-005) in australia

New york, jan. 29, 2021 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has been granted a patent from the...
SEEL Ratings Summary
SEEL Quant Ranking